article thumbnail

The Funding Spree for Neuroscience Startups: Venture Capital, Angel Investors, and Big Pharma betting big on Neuroscience

Lloyd Price

In October 2018, pharmaceutical giant Pfizer and private-equity firm Bain Capital LP announced the formation of Cerevel Therapeutics LLC, a drug-discovery collaboration for central nervous system disorders. Pfizer aims to invest $150 million in biotech startups focused on neurometabolic disorders, neurodegeneration, and neuroinflammation.

BioTech 40
article thumbnail

Will Foot Ulcer Treatment Survive Medicare Rollback?

Insulin Nation

Shire Pharmaceuticals has created Dermagraft, a similar human cell-based dressing that also has become popular for treating diabetic foot ulcers. A 2003 study on Dermagraft undertaken throughout 35 U.S. In a recent Fierce Biotech article, CEO MacKay warned his staff of “heartbreaking” staff cuts to make the new pricing structure work.